高级搜索

基于人群的幽门螺杆菌筛查与治疗策略用于胃癌预防:WHO-IARC 2025年胃癌工作组报告解读

Population-Based Helicobacter Pylori Screen-and-Treat Strategies for Gastric Cancer Prevention: An Interpretation of WHO–IARC 2025 Gastric Cancer Working Group Report

  • 摘要: 胃癌是全球范围内严重威胁人类生命健康的重大公共卫生问题,根除幽门螺杆菌(H. pylori)感染是开展胃癌一级预防的关键手段。2025年4月,世界卫生组织国际癌症研究机构发布了新版胃癌工作组报告,系统提出了基于人群的H. pylori筛查与治疗策略,全面阐述了从需求与准备情况评估、检测与治疗方案选择、抗生素耐药管理,到质量保障体系构建、健康公平性促进和成本效益优化等核心实施要素,旨在为全球胃癌预防实践提供科学指导。本文对该报告进行了全面梳理与深度解读,并结合我国胃癌防控现状,探讨其对制定与实施符合我国国情、更具成本效益的本土化人群H. pylori筛查与治疗策略的借鉴意义。

     

    Abstract: Gastric cancer remains a significant public health challenge globally, posing a severe threat to human health. Eradication of Helicobacter pylori (H. pylori) infection is the key to the primary prevention of gastric cancer. In April 2025, the World Health Organization-International Agency for Research on Cancer (WHO-IARC) released the new version of the Gastric Cancer Working Group Report. The report systematically details essential components for the implementation of population-based H. pylori screen-and-treat strategies, including an assessment of needs and readiness, selection of detection methods and treatment regimens, antibiotic stewardship, improvement of quality and equity, and optimization of cost-effectiveness, aiming to provide scientific guidance for global gastric cancer prevention efforts. This article presents a comprehensive review and in-depth analysis of the WHO-IARC report. This article explores the report's implications for developing and implementing cost-effective, localized, population-based H. pylori screen-and-treat strategies in the context of gastric cancer prevention and control in China.

     

/

返回文章
返回